Deadline for pre-proposal submission:
THE CALL IS CLOSED! Find out more
07 January 2021
09 March 2021; 14:00 CET
Neurological and mental disorders impose a high societal and economic burden to the European population, leading to costs of more than 800 billion euros per year. A wide range of brain disorders already manifests during development in early life. Such neurodevelopmental disorders severely curtail the quality of life of patients and their families often throughout their entire lifespan. Thus, neuroscientific research on neurodevelopmental disorders and its translation into diagnostic and therapeutic outcomes is a central pillar to promote healthy living in Europe and worldwide.
To address this topic, the 'Network of European Funding for Neuroscience Research' (NEURON) aims to coordinate research efforts and funding programmes across Europe and beyond to promote disease-related biomedical research on neurodevelopmental disorders. NEURON particularly wishes to encourage multidisciplinary approaches and translational research proposals combining basic and clinical research that will ultimately help to develop new strategies for prevention, diagnosis, therapy, and rehabilitation. With this aim, 22 funding organisations from 20 countries launched a Joint Transnational Call for Research Proposals on ‘Neurodevelopmental Disorders’.
Please check carefully the country-specific information for each research partner for further information on eligibility and parallel national regulations and requirements
Find out more …
► Call text: Read more about this call’s purpose, aims, and application procedures.
► Country-specific information: Please study thoroughly the regulations for your country/region
► Contact persons: It is strongly recommended that applicants call their national/regional contact person prior to submitting a proposal.
► Partnering: For assistance to find suitable research partners use the Partnering Tool.
ERA-NET NEURON Joint Call Secretariat
Project Management Agency (DLR-PT)
Dr. Christina Müller
phone: +49 228 3821-2182